Infectious peritonitis
diseaseOn this page
Also known as acute generalised peritonitis
Summary
Infectious peritonitis (MONDO:0004522) is a disease and 7 clinical trials. A subtype of infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 7
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | infectious peritonitis |
| Mondo ID | MONDO:0004522 |
| EFO | EFO:0008588 |
| DOID | DOID:8283 |
| ICD-10-CM | K65 |
| NCIT | C26849 |
| SNOMED CT | 86422009 |
| UMLS | C1264610 |
| MedGen | 688825 |
| Is cancer (heuristic) | no |
Also known as: acute generalised peritonitis
Disease family
This is a subtype of infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › infectious peritonitis
Related subtypes (34): infective endocarditis, hirudiniasis, fungal infectious disease, epididymitis, viral infectious disease, bacterial infectious disease, parasitic infectious disease, abscess, Ciliophora infectious disease, hookworm infectious disease, infectious embryofetopathy, mycetoma, infectious disorder of the nervous system, ear infection, sexually transmitted disease, puerperal infection, Acanthamoeba infectious disease, infectious myositis, infective vaginitis, skin disorder caused by infection, respiratory tract infectious disorder, nail infection, infective arthritis, digestive system infectious disorder, nosocomial infection, eye infectious disorder, prosthesis-related infectious disease, vector-borne disease, coinfection, urinary tract infection, hemorrhagic fever, protothecosis, pythiosis, infectious disease with sepsis
Subtypes (3): diphtheritic peritonitis, septic peritonitis, tuberculous peritonitis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
Drugs indicated for this disease
3 approved, 10 in late-stage (phase 3) trials. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.
| Drug | Development status |
|---|---|
| Anidulafungin | Approved (phase 4) |
| Ceftazidime | Approved (phase 4) |
| Clindamycin Phosphate | Approved (phase 4) |
| Cefotaxime | Phase 3 (in late-stage trials) |
| Ceftriaxone | Phase 3 (in late-stage trials) |
| Ciprofloxacin | Phase 3 (in late-stage trials) |
| Co-Trimoxazole | Phase 3 (in late-stage trials) |
| Doripenem | Phase 3 (in late-stage trials) |
| Gemifloxacin | Phase 3 (in late-stage trials) |
| Itopride | Phase 3 (in late-stage trials) |
| Nitazoxanide | Phase 3 (in late-stage trials) |
| Norfloxacin | Phase 3 (in late-stage trials) |
| Rifaximin | Phase 3 (in late-stage trials) |
Clinical trials & evidence
Clinical trials
Clinical trials: 7.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 6 |
| PHASE4 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02940730 | PHASE4 | COMPLETED | Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients |
| NCT07232342 | Not specified | RECRUITING | Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes |
| NCT07429929 | Not specified | NOT_YET_RECRUITING | Saudi Emergency Laparotomy Audit |
| NCT03140748 | Not specified | COMPLETED | Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation |
| NCT05264571 | Not specified | COMPLETED | Early Identification of Candida in Intra-abdominal Candidiasis |
| NCT07005258 | Not specified | COMPLETED | Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients |
| NCT07562204 | Not specified | COMPLETED | Rapid Identification of Microbial Pathogens in Intra-abdominal Infections Using Multiplex PCR |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.